ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Emergency Contraceptive Pills Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå
:
1595687
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 11¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 170 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
ÁÖ¿ä ÀλçÀÌÆ®
ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð(2024³â) : 7¾ï 4,040¸¸ ´Þ·¯
¿¹Ãø ½ÃÀå ±Ý¾×(2031³â) : 9¾ï 5,480¸¸ ´Þ·¯
¼¼°è ½ÃÀåÀÇ ¼ºÀå·ü(2024-2031³â CAGR) : 3.7%
ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§
ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå¿¡´Â ÇÇÀÓ ¾øÀÌ ¼º°ü°è¸¦ °¡Áø ÈÄ ÀÓ½ÅÀ» ¿¹¹æÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â º¹ÇÕ ÇÇÀÓ¾à, ÇÁ·Î°Ô½ºÅ×·Ð Àü¿ë ÇÇÀÓ¾à ¹× ±âŸ ÀÀ±Þ ÇÇÀÓ¾àÀÌ Æ÷ÇԵ˴ϴÙ. µµ½ÃÈÀÇ ÁøÀü°ú¼º °Ç° ±Ô¹üÀÇ º¯È¿¡µµ ºÒ±¸Çϰí ÇÇÀÓ¾à º¹¿ëÀÇ ½Ã°£Àû Á¦¾à°ú ÀÀ±ÞÇÇÀÓ¾àÀÇ ºÎÀÛ¿ë°ú °°Àº ¿äÀÎÀÌ ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀϺΠÁö¿ª¿¡¼´Â »çȸÀû ³«ÀÎ, ÀÎ½Ä ºÎÁ·, ÀûÀýÇÑ ÇÇÀÓ ¿É¼Ç¿¡ ´ëÇÑ Á¦ÇÑµÈ Á¢±Ù¼º µîÀÌ ÀÌ·¯ÇÑ Á¦Ç°ÀÇ Ã¤ÅÃÀ» ´õ¿í ¾î·Æ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀåÀº¼º °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á±â°üÀÇ Áö¿ø, ´õ ³ªÀº °¡Á· °èȹ ¹æ¹ýÀÇ È«º¸¿Í °°Àº ¿äÀο¡ ÀÇÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â International Consortium for Emergency Contraception°ú °°Àº ´ÜüÀÇ Áö¿øÀ¸·Î ÀÎÇØ ÀÀ±ÞÇÇÀÓ¾àÀÇ Áß¿äÇÑ ½ÃÀåÀ¸·Î ³²À» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¸¹Àº »ç¿ëÀÚµéÀÌ ºÎÀÛ¿ë°ú ½Ã°£°úÀÇ ½Î¿òÀ̶ó´Â Á¦Ç° Ư¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ Ç¥¸íÇϰí ÀÖÀ¸¸ç, º¸±ÞÀÌ Á¦ÇÑÀûÀÌ¾î¼ ¼ºÀåÀÌ Á¦ÇÑÀûÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
ÀÀ±ÞÇÇÀÓ¾à ½ÃÀåÀÌ Á÷¸éÇÑ ¹®Á¦·Î´Â Àû½Ã º¹¿ë¿¡ ´ëÇÑ ³ôÀº ÀÇÁ¸µµ, ¸Þ½º²¨¿ò, ºÎÁ¤ÃâÇ÷°ú °°Àº ºÎÀÛ¿ë, ¼ºº´(STI) ¿¹¹æ È¿°úÀÇ ºÎÁ· µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÇÀÓ¾àÀº ¼ºº´À» ¿¹¹æÇÏÁö ¸øÇϹǷΠÀϺΠºÎ¹®¿¡¼ È£¼Ò·ÂÀÌ ¶³¾îÁö°í ÀÖ½À´Ï´Ù. ÀÀ±ÞÇÇÀÓ¾àÀÌ ÀÏ¹Ý ÇÇÀӾ࿡ ºñÇØ ´ú ¼±È£µÇ´Â ¼±ÅÃÀ̶ó´Â ÀνÄÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ
ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀο¡µµ ºÒ±¸ÇÏ°í ºÎÀÛ¿ëÀÌ ÀûÀº ÀÀ±ÞÇÇÀÓ¾àÀÇ °³¹ß·Î ÀÎÇØ ½ÃÀå º¸±Þ·üÀÌ ³ô¾ÆÁú °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº °³¼±µÈ Á¦Çü °³¹ß¿¡ ÁýÁßÇϰí ÀÖÀ¸¸ç, º´¿ø ¾à±¹ ¹× Á¶Á÷ÈµÈ ¼Ò¸Å ä³ÎÀ» ÅëÇØ ½±°Ô ±¸ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ NGO ¹× Á¤ºÎ ±â°üÀÇ ±³À° Ȱµ¿ °È´Â ¿ÀÇØ¸¦ ÇØ¼ÒÇÏ°í ¾ÈÀüÇÑ ÀÀ±ÞÇÇÀÓ¾à »ç¿ëÀ» ÃËÁøÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù.
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ÃËÁø¿äÀÎ, »õ·Î¿î µ¿Çâ, °úÁ¦, ÇâÈÄ ±âȸ µîÀÇ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå °³¿ä
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ·ù
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå Á¤ÀÇ
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀåÀÇ Àü³â´ëºñ ¼ºÀå
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ¿ªÇÐ
°ø±Þ¸Á
ºñ¿ë ±¸Á¶
°¡°Ý ºÐ¼®
¿øÀç·á Á¶´Þ Àü·«°ú ºÐ¼®
ÆÇ¸Å¾÷ü ¸®½ºÆ®
ÁÖ¿ä Âü¿© ±â¾÷ÀÇ ½ÃÀå ÀÔÁö : Áö¿ªº°(°µµ ¸Ê)
Á¦3Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° À¯Çüº°
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç° À¯Çüº°(2024-2031³â)
º¹ÇÕ ÇÊ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
ÇÁ·Î°Ô½ºÅ×·Ð ÇÊ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¿¡½ºÆ®·Î°Õ ÇÊ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
±âŸ Á¦Ç°ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
Á¦4Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÆÇ¸Åä³Îº°
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ÆÇ¸Åä³Îº° ¿¹Ãø(2024-2031³â)
µå·¯±×½ºÅä¾î/¾à±¹ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
º´¿ø ¾à±¹ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¿Â¶óÀÎ Æ®·¹ÀÌ´õ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
±âŸ ä³Î ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
Á¦5Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°
¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
ºÏ¹ÌÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
À¯·´ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
ÀϺ»ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¾Æ½Ã¾ÆÅÂÆò¾ç(ÀϺ» Á¦¿Ü) ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
Á¦6Àå ºÏ¹ÌÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
¹Ì±¹ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
ij³ª´ÙÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
Á¦7Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
ºê¶óÁúÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
¸ß½ÃÄÚÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
¾Æ¸£ÇîÆ¼³ªÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
Á¦8Àå À¯·´ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
µ¶ÀÏÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
¿µ±¹ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
ÇÁ¶û½ºÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
½ºÆäÀÎÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
ÀÌÅ»¸®¾ÆÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
ºÏÀ¯·´ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
Á¦9Àå ÀϺ»ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
ÀϺ»ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç(ÀϺ» Á¦¿Ü) ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
Áß±¹ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
ÀεµÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
¸»·¹ÀÌ½Ã¾Æ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
ű¹ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
½Ì°¡Æ÷¸£ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
È£ÁÖÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)
GCC ±¹°¡ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
³²¾ÆÇÁ¸®Ä«°øÈ±¹ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
³ªÀÌÁö¸®¾ÆÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
À̽º¶ó¿¤ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2031³â)
¸ÅÃâ ºñ±³ : Á¦Ç° À¯Çüº°
¸ÅÃâ ºñ±³ : ÆÇ¸Åä³Îº°
Á¦12Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±â¾÷/Á¦Á¶¾÷ü/ÆÇ¸Å¾÷ü/°ø±Þ¾÷ü °³¿ä¿Í ¸ÅÃâ ¿¹Ãø
±â¾÷ Á¡À¯À² ºÐ¼® : Áö¿ªº°
Teva Pharmaceutical Industries Ltd
Laboratoire HRA Pharma
Bayer AG
Xianju Pharmaceutical Co Ltd
Piramal Enterprises Ltd
Mankind Pharma Ltd
Richter Gedeon Nyrt
Lupin Ltd
Cooper Pharma
Pfizer Inc
Á¦13Àå Á¶»ç ¹æ¹ý
Á¦14Àå 2Â÷ ÀÚ·á¿Í 1Â÷ ÀÚ·á
Á¦15Àå ÀüÁ¦Á¶°Ç°ú µÎÀÚ¾î
Á¦16Àå ¸éÃ¥»çÇ×
KSA
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently released a comprehensive report on the global Emergency Contraceptive Pills Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, challenges, and future opportunities. This report offers a detailed overview of the market landscape, supporting stakeholders in making well-informed decisions.
Key Insights:
Emergency Contraceptive Pills Market Size (2024E): US$ 740.4 Mn
Projected Market Value (2031F): US$ 954.8 Mn
Global Market Growth Rate (CAGR 2024 to 2031): 3.7%
Emergency Contraceptive Pills Market - Report Scope:
The Emergency Contraceptive Pills market encompasses a range of products used to prevent pregnancy following unprotected intercourse. This market includes combination pills, progesterone-only pills, and other emergency contraceptives. Despite increasing urbanization and changing sexual health norms, factors like time constraints for pill intake and side effects associated with emergency contraceptive pills are expected to impact the market's growth negatively. Social stigmas, lack of awareness, and limited access to proper contraceptive options in some regions further challenge the adoption of these products.
Market Drivers:
The market's growth is being shaped by factors such as the increasing awareness about sexual health, support from healthcare organizations, and the drive for better family planning methods. North America is projected to remain a significant market for emergency contraceptive pills due to advocacy from organizations like the International Consortium for Emergency Contraception. However, growth is limited as many users express concerns over side effects and the time-sensitive nature of these products, which discourages widespread adoption.
Market Restraints:
Challenges facing the Emergency Contraceptive Pills market include high reliance on timely intake, side effects like nausea and irregular bleeding, and the lack of efficacy in preventing sexually transmitted infections (STIs). These pills do not protect against venereal diseases, which reduces their appeal in some segments. The perception of emergency contraception as a less-preferred option compared to regular contraceptives further constrains the market's growth.
Market Opportunities:
Despite these restraints, the market presents opportunities through the development of emergency contraceptives with fewer side effects, which could encourage higher adoption. Manufacturers are focusing on creating improved formulations and expanding accessibility through hospital pharmacies and organized retail channels. Furthermore, increased educational initiatives by NGOs and government agencies aim to address misconceptions and promote safe emergency contraceptive practices.
Key Questions Answered in the Report:
What factors are restraining the growth of the Emergency Contraceptive Pills market?
Which regions are anticipated to see a rise in the demand for emergency contraceptives?
How do societal perceptions impact the sales of emergency contraceptive pills?
Who are the leading companies in the market, and what strategies are they employing?
What are the emerging trends in the global Emergency Contraceptive Pills market?
Competitive Intelligence and Business Strategy:
Leading companies in the Emergency Contraceptive Pills market, including Bayer AG, Teva Pharmaceutical Industries Ltd., and Pfizer Inc., focus on research and development to improve product efficacy and reduce side effects. Partnerships with healthcare providers and initiatives to enhance accessibility are pivotal for their market presence. These companies emphasize affordability, safety, and effective marketing to improve product perception, which is crucial for competing in this challenging market.
Key Companies Profiled:
Teva Pharmaceutical Industries Ltd.
Bayer AG, HRA Pharma
Piramal Enterprises Limited
Mankind Pharma Ltd.
Richter Gedeon Nyrt
Lupin Limited
Cooper Pharma
Pfizer Inc.
Zhejiang Xianju Pharmaceutical Co.
Others
Emergency Contraceptive Pills Market Segmentation:
By Product Type:
Combination Pills
Progesterone Pills
Estrogen Pills
Other Products
By Sales Channel:
Drug Stores/Pharmacies
Hospital Pharmacies
Online Traders
Other Channels
By Region:
North America
Latin America
Europe
Japan
Asia Pacific excluding Japan (APEJ)
Middle East & Africa (MEA)
Table of Contents
1. Executive Summary
2. Global Emergency Contraceptive Pills Market Overview
2.1. Introduction
2.1.1. Global Emergency Contraceptive Pills Market Taxonomy
2.1.2. Global Emergency Contraceptive Pills Market Definition
2.2. Global Emergency Contraceptive Pills Market Size (US$ Mn) and Forecast, 2024-2031
2.2.1. Global Emergency Contraceptive Pills Market Y-o-Y Growth
2.3. Global Emergency Contraceptive Pills Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Cost Structure
2.6. Pricing Analysis
2.7. Raw Material Sourcing Strategy and Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Emergency Contraceptive Pills Market Analysis and Forecast By Product Type
3.1. Global Emergency Contraceptive Pills Market Size and Forecast By Product Type, 2024-2031
3.1.1. Combination Pills Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Progesterone Pills Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Estrogen Pills Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
3.1.4. Other Products Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
3.1.4.1. Revenue (US$ Mn) Comparison, By Region
3.1.4.2. Market Share Comparison, By Region
3.1.4.3. Y-o-Y growth Comparison, By Region
4. Global Emergency Contraceptive Pills Market Analysis and Forecast By Sales Channel
4.1. Global Emergency Contraceptive Pills Market Size and Forecast By Sales Channel, 2024-2031
4.1.1. Drug Stores/ Pharmacy Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Hospital Pharmacies Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Traders Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Other Channels Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
5. Global Emergency Contraceptive Pills Market Analysis and Forecast By Region
5.1. Global Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.1. North America Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.1.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
5.1.2. Latin America Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.2.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.2.2. Revenue (US$ Mn) Comparison, By Sales Channel
5.1.3. Europe Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.3.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.3.2. Revenue (US$ Mn) Comparison, By Sales Channel
5.1.4. Japan Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.4.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.4.2. Revenue (US$ Mn) Comparison, By Sales Channel
5.1.5. APEJ Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.5.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.5.2. Revenue (US$ Mn) Comparison, By Sales Channel
5.1.6. MEA Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
5.1.6.1. Revenue (US$ Mn) Comparison, By Product Type
5.1.6.2. Revenue (US$ Mn) Comparison, By Sales Channel
6. North America Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031
6.1. US Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
6.1.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
6.2. Canada Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
6.2.1. Revenue (US$ Mn) Comparison, By Product Type
6.2.2. Revenue (US$ Mn) Comparison, By Sales Channel
7. Latin America Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031
7.1. Brazil Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
7.1.1. Revenue (US$ Mn) Comparison, By Product Type
7.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
7.2. Mexico Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
7.2.1. Revenue (US$ Mn) Comparison, By Product Type
7.2.2. Revenue (US$ Mn) Comparison, By Sales Channel
7.3. Argentina Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
7.3.1. Revenue (US$ Mn) Comparison, By Product Type
7.3.2. Revenue (US$ Mn) Comparison, By Sales Channel
8. Europe Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031
8.1. Germany Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
8.1.1. Revenue (US$ Mn) Comparison, By Product Type
8.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
8.2. UK Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
8.2.1. Revenue (US$ Mn) Comparison, By Product Type
8.2.2. Revenue (US$ Mn) Comparison, By Sales Channel
8.3. France Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
8.3.1. Revenue (US$ Mn) Comparison, By Product Type
8.3.2. Revenue (US$ Mn) Comparison, By Sales Channel
8.4. Spain Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
8.4.1. Revenue (US$ Mn) Comparison, By Product Type
8.4.2. Revenue (US$ Mn) Comparison, By Sales Channel
8.5. Italy Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
8.5.1. Revenue (US$ Mn) Comparison, By Product Type
8.5.2. Revenue (US$ Mn) Comparison, By Sales Channel
8.6. Nordic Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
8.6.1. Revenue (US$ Mn) Comparison, By Product Type
8.6.2. Revenue (US$ Mn) Comparison, By Sales Channel
9. Japan Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031
9.1. Japan Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
9.1.1. Revenue (US$ Mn) Comparison, By Product Type
9.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
10. APEJ Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031
10.1. China Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
10.1.1. Revenue (US$ Mn) Comparison, By Product Type
10.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
10.2. India Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
10.2.1. Revenue (US$ Mn) Comparison, By Product Type
10.2.2. Revenue (US$ Mn) Comparison, By Sales Channel
10.3. Malaysia Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
10.3.1. Revenue (US$ Mn) Comparison, By Product Type
10.3.2. Revenue (US$ Mn) Comparison, By Sales Channel
10.4. Thailand Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
10.4.1. Revenue (US$ Mn) Comparison, By Product Type
10.4.2. Revenue (US$ Mn) Comparison, By Sales Channel
10.5. Singapore Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
10.5.1. Revenue (US$ Mn) Comparison, By Product Type
10.5.2. Revenue (US$ Mn) Comparison, By Sales Channel
10.6. Australia Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
10.6.1. Revenue (US$ Mn) Comparison, By Product Type
10.6.2. Revenue (US$ Mn) Comparison, By Sales Channel
11. MEA Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031
11.1. GCC Countries Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
11.1.1. Revenue (US$ Mn) Comparison, By Product Type
11.1.2. Revenue (US$ Mn) Comparison, By Sales Channel
11.2. South Africa Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
11.2.1. Revenue (US$ Mn) Comparison, By Product Type
11.2.2. Revenue (US$ Mn) Comparison, By Sales Channel
11.3. Nigeria Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
11.3.1. Revenue (US$ Mn) Comparison, By Product Type
11.3.2. Revenue (US$ Mn) Comparison, By Sales Channel
11.4. Israel Emergency Contraceptive Pills Market Size and Forecast, 2024-2031
11.4.1. Revenue (US$ Mn) Comparison, By Product Type
11.4.2. Revenue (US$ Mn) Comparison, By Sales Channel
12. Global Emergency Contraceptive Pills Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections
12.1. Company Share Analysis By Region
12.2. Teva Pharmaceutical Industries Ltd
12.2.1. Company Overview
12.2.2. Emergency Contraceptive Pills Market Product Type list
12.2.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.3. Laboratoire HRA Pharma
12.3.1. Company Overview
12.3.2. Emergency Contraceptive Pills Market Product Type list
12.3.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.4. Bayer AG
12.4.1. Company Overview
12.4.2. Emergency Contraceptive Pills Market Product Type list
12.4.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.5. Xianju Pharmaceutical Co Ltd
12.5.1. Company Overview
12.5.2. Emergency Contraceptive Pills Market Product Type list
12.5.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.6. Piramal Enterprises Ltd
12.6.1. Company Overview
12.6.2. Emergency Contraceptive Pills Market Product Type list
12.6.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.7. Mankind Pharma Ltd
12.7.1. Company Overview
12.7.2. Emergency Contraceptive Pills Market Product Type list
12.7.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.8. Richter Gedeon Nyrt
12.8.1. Company Overview
12.8.2. Emergency Contraceptive Pills Market Product Type list
12.8.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.9. Lupin Ltd
12.9.1. Company Overview
12.9.2. Emergency Contraceptive Pills Market Product Type list
12.9.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.10. Cooper Pharma
12.10.1. Company Overview
12.10.2. Emergency Contraceptive Pills Market Product Type list
12.10.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.11. Pfizer Inc
12.11.1. Company Overview
12.11.2. Emergency Contraceptive Pills Market Product Type list
12.11.3. Emergency Contraceptive Pills Market Product Type Sales Data and Key Financials
12.11.4. Key Developments
12.11.5. SWOT Analysis
13. Research Methodology
14. Secondary and Primary Sources
15. Assumptions and Acronyms
16. Disclaimer
°ü·ÃÀÚ·á